Cipla gets VAI classification from USFDA for Patalganga facility 0 25.06.2024 09:04 Business Standard Cipla said that US Food and Drug Administration (USFDA) classified the inspection conducted at Patalganga, Maharashtra facility as Voluntary Action Indicated (VAI). Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
